{"name":"NexThera Co., Ltd.","slug":"nexthera-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxPRWNQdGJ2MGthQkNiSFRQVnR4UmNxTk5LdTFJeFBGVGpoUlVjZXpabXBsSnk5UHlVemxnN1dIU2Q3ZzVKYThKaXg0SHRWX29icTZMS0c5TU4xcW4zRjF3N0JwTXV2WERfUG5ZazN6UzNDeFI0WjljMlNFcUhsYWU1aWRfWkNPMUVXc3d0V3dHTVpuOUlidkpmQmtULTVXZGpCdDhJMDdTeG1GMWZCalhSZGNza0FLazBVbl9USHg0S29wX2lfWm56QTJDNVhWVTNKS0kyaGJlYVNNMVd3QWxEWjNGVEY?oc=5","date":"2025-04-09","type":"trial","source":"BioSpace","summary":"NexThera Completes First Patient Enrollment in U.S. Clinical Trial for ‘NT-101,’ an Eye Drop Treatment for Wet AMD - BioSpace","headline":"NexThera Completes First Patient Enrollment in U.S. Clinical Trial for ‘NT-101,’ an Eye Drop Treatment for Wet AMD","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxONzlINmhwZG1KY2YzcXd2R3o1cHI0a3Axd3F3SlhIVmR5YmZpUHhQUDc1ellTeHhEcWg5RnhJdFdLT2VCRXdlLWUydHB0b3FvbXJBa1dYZVFtNzB5VFI3QUZ4eWZoZVpoMHlEV0NRZ3VrbFZLX19odzltZ3V6Ujcta19CNDJwN0ZxcW4xbGo0VmlPUWVKMXVLTW1CYUpsbTZLWlp0SzdR?oc=5","date":"2024-07-17","type":"pipeline","source":"BioWorld News","summary":"Nexthera files IND application for NT-101 eye drop for wet AMD - BioWorld News","headline":"Nexthera files IND application for NT-101 eye drop for wet AMD","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}